Navigation Links
ALL: More Dead Babies Found in Michigan Dumpsters
Date:5/8/2008

es and is committed to the protection of all innocent human beings from the moment of creation to natural death. For more information or media inquiries, please contact Michael Hichborn at 540.659.7900.

FOR MORE INFORMATION:

Citizens for a Pro-Life Society: "More Aborted babies Found in Dumpster" (07

May 2008)

http://www.prolifesociety.com/displaypages/pages/home.aspx

PRO-LIFE pulse: Another MI Abortionist Trashes Babies in Dumpster (07 May

2008)

http://www.jillstanek.com/archives/2008/05/breaking_news_a.html#more

Catholic News Agency: "Bishop Quinn to hold memorial Mass for 25 aborted

babies" (03 May 2008)

http://catholicnewsagency.com/new.php?n=12539

Reuters: "ALL: Throw Babies in Dumpster, Get a Slap on the Wrist???" (27

March 2008)

http://www.reuters.com/article/pressRelease/idUS153341+27-Mar-2008+PRN2 0080327

American Life League: "Worthless Bodies in a Wicked World: Hodari Pays No

Price" (27 March 2008)

http://www.all.org/article_printerfriendly.php?id=11340

CONTACT: Michael Hichborn of American Life League, +1-540-226-9178, mhichborn@all.org


'/>"/>
SOURCE American Life League
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Stressed-Out Moms Carry Babies on the Right
2. March of Dimes, Experts for Moms and Babies, Launches Podcast
3. Steroids Seem Safe for Babies at Risk of Early Birth
4. Babies raised in bilingual homes learn new words differently than infants learning one language
5. Motherhood(R) Maternity Joins March of Dimes to Give Babies a Healthy Start in Life
6. Photo: Introducing a New Line of Baby and Toddler Shirts that Can Help Protect Innocent Babies During Flu Season
7. YouTube Video to Benefit AIDS Babies
8. Treadmill training helps Down syndrome babies walk months earlier
9. March of Dimes Honors Babies on El Dia de Todos los Santos
10. Common drug for stopping preterm labor may be harmful for babies
11. Babies Driving Robots at University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... Results of two new studies support the use ... (AED) Vimpat® for patients requiring add-on therapy in ... not feasible. These data, which were presented ... the American Epilepsy Society in Boston, further clarify ... setting. ,, One study shows that patients can ...
(Date:12/7/2009)... -- Micromet, Inc. (Nasdaq: MITI ), a ... treatment of cancer, inflammation and autoimmune diseases, today ... data from its ongoing phase 1 clinical trial ... non-Hodgkin,s lymphoma (NHL) at the 51ST Annual Meeting ... New Orleans, Louisiana. Blinatumomab is a CD19-specific, T ...
(Date:12/7/2009)... couple years ago, lead paint in toys manufactured ... made in the USA. This fall, news of ... toys are suspect. Renowned parenting expert Dr. Jeffrey ... harmful to developing brains, retarding language development and ... sense of separation, which is the defining trait ...
(Date:12/7/2009)... Barduson was recently named executive chairman of the board of ... physicians in hospitals and practices nationwide. , ... ... Gene Barduson was recently named executive chairman of the ... company currently serving 13,000 physicians in hospitals and practices nationwide. ...
(Date:12/7/2009)... PALM BEACH, Fla., Dec. 7 The ... TransMedia Group to publicize the first major ... the Simply 66 Snap System, which is already ... TransMedia Group ( www.transmediagroup.com ) was selected as ... profile in print, broadcast, online and social networking ...
Breaking Medicine News(10 mins):Health News:New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings 2Health News:New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings 3Health News:New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings 4Health News:New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings 5Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 2Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 3Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 4Health News:Top 10 Toys That Will Scar Your Child for Life 2Health News:Gene Barduson Named Chairman of PerfectServe Board of Directors 2Health News:Cubicle Curtain Factory Retains TransMedia Group to Promote First Privacy Curtain to Reduce Hospital Maintenance Cost 2
... indoor plumbing to be the pinnacle of sanitary ... better solution for many parts of the developing ... Associate Professor David Watkins, Professor James Mihelcic and ... Futures Institute analyzed worldwide barriers to sanitation. Diseases ...
... the hormone could boost death risk, researchers say , , ... levels put men at high risk for cardiovascular disease, ... help better the odds, according to new studies. ... become more common with age, are linked to several ...
... in the strength of cannabis over the last decade is ... users are not borne out by a study of the ... Research Centre (NDARC) and the National Drug Research Institute (NDRI), ... this month,s issue of ADDICTION, are that increased potency has ...
... Health Care & Economic Security - Need,for Lawmakers to ... 17 150 years ago,this week, Abraham Lincoln delivered ... Springfield. AARP Illinois took the opportunity,to remind state and ... of division preventing progress on key issues remains the,same., ...
... creators of the leading exergaming ,Brand Xperience, ... the exergaming market in ... iTech Fitness Inc.,( http://www.iTechFitness.com ), creators of the ... signing of the 50th XRKade,location in North America with ...
... Associates, leading analysts will,explore the implications of high-speed ... homes as a kickoff to CONNECTIONS(TM): The,Digital Living ... Top Trends to Watch, Tuesday, June 24,will feature ... on trends in,broadband and access services, video delivery, ...
Other Medicine News:Health News:Studies Support Testosterone Supplements for Older Men 2Health News:Claims linking health problems and the strength of cannabis may be exaggerated 2Health News:150 Years Later 'House Divided' Speech Still Holds Strong Message 2Health News:XRKade Signs 50th Location in North America and Announces Expansion Plans 2Health News:Parks Associates Analysts Present Insights on Broadband, Digital Content, Advertising, Home Systems, and Digital Health at CONNECTIONS(TM) 2
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense ... announced today the presentation of new data from the ... Protective Antigen (rPA) based anthrax vaccine is structurally stable ... to and including 55 degrees C. The data ...
(Date:12/4/2009)... LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: ... and medication delivery company, today announced the launch of ... for intravenous (I.V.) medications and solutions, and now offers ... of the award-winning, environmentally responsible VisIV product. The launch ...
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), ... and chemical threats, announced today that the Company ... effectiveness of Valortim® in an inhalation anthrax model ... The data are being presented during an oral ...
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Health Insurance Reform DAILY MYTHBUSTER 3A Constitutionality of Health Insurance Reform 57439 1Health Insurance Reform DAILY MYTHBUSTER 3A Constitutionality of Health Insurance Reform 57439 2Health Insurance Reform DAILY MYTHBUSTER 3A Constitutionality of Health Insurance Reform 57439 3Baucus Bill Imposes Additional Tax Burdens on Nonprofit Hospitals 57437 1Baucus Bill Imposes Additional Tax Burdens on Nonprofit Hospitals 57437 2Senate Finance Committee Cuts Home Medical Equipment in Reform Package 57435 1Senate Finance Committee Cuts Home Medical Equipment in Reform Package 57435 2
... BIRMINGHAM, Ala., July 10 BioCryst,Pharmaceuticals, Inc. (Nasdaq: ... study of intramuscular (i.m.) peramivir for the treatment of,seasonal ... trial,will compare the efficacy of a single 600 mg ... seasonal influenza. The dose was selected based,upon an analysis ...
... July 9 Summary: Genmab,has completed recruitment of ... combination with fludarabine and cyclophosphamide to treat front ... it has completed recruitment of,56 patients in the ... with fludarabine and cyclophosphamide (FC) to treat chronic,lymphocytic ...
Other Medicine Technology:BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza 2BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza 3BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza 4Genmab A/S - Company Announcement: Recruitment Completed In Ofatumumab CLL Front Line Study 2Genmab A/S - Company Announcement: Recruitment Completed In Ofatumumab CLL Front Line Study 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: